My how things have changed. In May Shocking The Street, a premium investment service in conjunction with Seeking Alpha, intimated a drug in Endo’s pipeline could make ENDP a 4 bagger. The stock is up over 75% since. According to Shocking The Street, Endo’s CEO Paul Campanelli recently indicated the company could accelerate timeline for this key drug. Read more:
